- Home Page
- Sales & Partners
- News & Events
- Site Map
|Method & Line||Sample & Target||Product||Package Info|
|MicroELISA||Plasma,Serum||EIAgen Herpes Simplex Virus IgG Kit||Tests per Package: 96|
|EIAgen||Enzyme ImmunoAssay (ELISA) for the quantitative/qualitative determination of IgG antibodies to Herpes Simplex Virus type 1 and 2 in human plasma and sera. For “in vitro” diagnostic use only.||Code: 091007||Package: 1 Microplate|
Please pay attention to the revision of the document that must be the same as the revision reported in the box label.
In case of discrepancy please contact our Customer Care e-mail: firstname.lastname@example.org.
* Other document related to the product available at Documentation Centre and it is accessible for Adaltis distributors/partners after registration only.
Enzyme ImmunoAssay (ELISA) for the quantitative/qualitative determination of IgG antibodies to Herpes Simplex Virus type 1 and 2 in human plasma and sera. For “in vitro” diagnostic use only.
Herpes Simplex Virus type 1 (HSV1) and type 2 (HSV2) are large complex DNA-containing viruses which have been shown to induce the synthesis of several proteins during infection, possessing an high number of crossreactive determinants and just a few of type-specific sequences.
The majority of primary and recurrent genital herpetic infections are caused by HSV2; while non genital infections, such as common cold sores, are caused primarily by HSV1.
The detection of virus specific IgG and IgM antibodies are important in the diagnosis of acute/primary virus infections or reactivations of a latent one, in the absence of evident clinical symptoms.
Asymptomatic infections may happen for HSV in apparently healthy individuals and during pregnancy. Severe herpetic infections may happen in immunocompromised and suppressed patients in which the disease may evolve toward critical pathologies.
The determination of HSV specific antibodies has then become important in the monitoring of “risk” patients and in the follow up of acute and severe infections.
Microplates are coated with native inactivated HSV1 and HSV2.
The solid phase is first treated with the diluted sample and IgG to HSV are captured, if present, by the antigens.
After washing out all the other components of the sample, in the 2nd incubation bound anti HSV IgG are detected by the addition of polyclonal specific anti hIgG antibodies, labelled with peroxidase (HRP).
The enzyme captured on the solid phase, acting on the substrate/chromogen mixture, generates an optical signal that is proportional to the amount of anti HSV IgG antibodies present in the sample. A Calibration Curve, calibrated against an internal Gold Standard, makes possible a quantitative determination of the IgG antibody in the patient.
Each kit contains sufficient reagents to perform 96 tests (code 091007).
Calibrator 1 / 2 / 6
Calibrator 3 / 4 / 5
Wash Buffer Concentrate 20x
Plate seal foils
Number of tests